Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R van Straalen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The British Journal of Dermatology|July 8, 2018
Current and future treatment of hidradenitis suppurativaK R van Straalen, S Schneider-Burrus, E P Prens
Journal of the European Academy of Dermatology and Venereology : JEADV|December 19, 2023
Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativaP Aarts, J C van Huijstee, H H van der Zee, et al.
The British Journal of Dermatology|February 5, 2021
Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort studyL M Prens, K Bouwman, P Aarts, et al.
Frontiers in Immunology|October 10, 2022
Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?K R van Straalen, K Dudink, P Aarts, et al.
The British Journal of Dermatology|December 5, 2018
Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessmentA Rondags, K R van Straalen, J R van Hasselt, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
A genome-wide association study of hidradenitis suppurativa from the VA's Million Veteran ProgramZachary Wendland, Craig C Teerlink, Kathryn M Pridgen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 21, 2020
A novel nicastrin mutation in a three-generation Dutch family with hidradenitis suppurativa: a search for functional significanceA R J V Vossen, K R van Straalen, S M A Swagemakers, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2018
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working groupC C Zouboulis, F G Bechara, J L Dickinson-Blok, et al.
JCI Insight|August 28, 2020
Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesisJohann E Gudjonsson, Lam C Tsoi, Feiyang Ma, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 19, 2024
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: TreatmentC C Zouboulis, F G Bechara, F Benhadou, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The British Journal of Dermatology|July 8, 2018
Current and future treatment of hidradenitis suppurativaK R van Straalen, S Schneider-Burrus, E P Prens
Journal of the European Academy of Dermatology and Venereology : JEADV|December 19, 2023
Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativaP Aarts, J C van Huijstee, H H van der Zee, et al.
The British Journal of Dermatology|February 5, 2021
Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort studyL M Prens, K Bouwman, P Aarts, et al.
Frontiers in Immunology|October 10, 2022
Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?K R van Straalen, K Dudink, P Aarts, et al.
The British Journal of Dermatology|December 5, 2018
Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessmentA Rondags, K R van Straalen, J R van Hasselt, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
A genome-wide association study of hidradenitis suppurativa from the VA's Million Veteran ProgramZachary Wendland, Craig C Teerlink, Kathryn M Pridgen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 21, 2020
A novel nicastrin mutation in a three-generation Dutch family with hidradenitis suppurativa: a search for functional significanceA R J V Vossen, K R van Straalen, S M A Swagemakers, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2018
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working groupC C Zouboulis, F G Bechara, J L Dickinson-Blok, et al.
JCI Insight|August 28, 2020
Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesisJohann E Gudjonsson, Lam C Tsoi, Feiyang Ma, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 19, 2024
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: TreatmentC C Zouboulis, F G Bechara, F Benhadou, et al.
Pageof 1